At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 100 enrolled
Drug / intervention
Haloperidol + Promethazine + Chlorpromazine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
TREC-Lebanon Trial: A Randomised Controlled Trial for Rapid Tranquilisation for Agitated Patients in the Emergency Setting
In Brief
A Phase 4 clinical trial evaluating Haloperidol + Promethazine + Chlorpromazine and Haloperidol + Promethazine for Psychiatric Emergency and 2 related conditions. Completed, enrolled 100 participants across 2 sites.
Detailed Summary
This is a randomised controlled trial comparing haloperidol + promethazine versus haloperidol + promethazine + chlorpromazine for agitated patients in the emergency department.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPsychiatric Emergency, Aggression, Agitation
CountriesLebanon
CollaboratorsUniversity of Nottingham, Hopital Psychiatrique De La Croix
Timeline
Phase 4CompletedFinished
20192020202120222023202420252026
First PostedAug 2018
Enrollment StartAug 2018
Primary CompletionJul 2019
Study CompletionJul 2019
TodayJul 2026
First PostedAug 21, 2018
Enrollment StartAug 28, 2018
Primary CompletionJul 1, 2019
Study CompletionJul 7, 2019
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 7.9 years ago
Interventions
Haloperidol + Promethazine + Chlorpromazinedrug
This is the usual treatment given by this hospital during an aggressive psychiatric episode.
Haloperidol + Promethazinedrug
This is the second most used psycho-pharmacological combination used in this hospital during an aggressive psychiatric episode.